{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/sore-throat-acute/","result":{"data":{"firstChapter":{"id":"81404cee-5cce-5697-afc1-b29dbea3cf99","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 7e375cb0-2800-4340-b548-d87e90479786 --><h1>Sore throat - acute: Summary</h1><!-- end field 7e375cb0-2800-4340-b548-d87e90479786 -->","htmlStringContent":"<!-- begin item 0f282588-fad0-41ec-99df-7db7e76b1afc --><!-- begin field 1f43df31-b8a6-4bad-b7bf-d00fe3b22fda --><ul><li>The term 'sore throat' describes the symptom of pain at the back of the mouth. Clinical descriptions of acute sore throat include:<ul><li>Acute pharyngitis: inflammation of the part of the throat behind the soft palate (oropharynx).</li><li>Tonsillitis: inflammation of the tonsils.</li></ul></li><li>Acute sore throat is usually caused by a viral or bacterial infection. Non-infectious causes are uncommon and include physical irritation from gastro-oesophageal reflux disease or chronic cigarette smoke, and hayfever.</li><li>Common causes of sore throat in primary care are usually not life-threatening and include common cold, influenza, streptococcal infection, and infectious mononucleosis.</li><li>Less common causes include HIV, gonococcal pharyngitis, and diphtheria.</li><li>Acute throat infections most commonly occur in people aged 5–24 years.</li><li>Complications include otitis media (most common), peri-tonsillar abscess (quinsy), and parapharyngeal abscess.</li><li>Sore throat due to a viral or bacterial cause is a self-limiting condition. Symptoms resolve within 3 days in 40% of people, and within 1 week in 85% of people, irrespective of whether or not the sore throat is due to a streptococcal infection.</li><li>The symptoms of infectious mononucleosis usually resolve within 1–2 weeks although mild cases may resolve within days. However, lethargy continues for some time afterwards and in rare cases may continue for months or years.</li><li>Management of a person presenting with a sore throat involves:<ul><li>Admitting the person immediately if they have stridor, breathing difficulty, clinical dehydration, or a condition that is immediately life-threatening such as acute epiglottis or Kawasaki disease.</li><li>Referring people with a suspected serious but not immediately life-threatening cause for sore throat (such as cancer or HIV).</li><li>Giving simple advice, if appropriate, for example, regular use of paracetamol or ibuprofen to relieve pain and fever, and adequate fluid intake to avoid dehydration until the discomfort and swelling subside.</li><li>Prescribing antibiotic treatment, if appropriate. FeverPAIN and Centor clinical prediction scores should be used to assist the decision on whether to prescribe an antibiotic.</li><li>Arranging specialist assessment for people with recurrent tonsillitis (a frequency of more than 7 episodes per year for one year, 5 per year for 2 years, or 3 per year for 3 years) as they may benefit from tonsillectomy.</li></ul></li></ul><!-- end field 1f43df31-b8a6-4bad-b7bf-d00fe3b22fda --><!-- end item 0f282588-fad0-41ec-99df-7db7e76b1afc -->","topic":{"id":"b9203bc1-aec0-515e-b8a8-df5fbd75f255","topicId":"a235ee81-d6c7-4837-95b1-fc8ac97489f1","topicName":"Sore throat - acute","slug":"sore-throat-acute","aliases":[],"chapters":[{"id":"81404cee-5cce-5697-afc1-b29dbea3cf99","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"7b8dd3db-314e-5c48-8169-957babf68c00","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"3f5b8783-adcd-5d7a-9330-002285fe81e4","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"ecd64c56-4cd5-5be5-a040-00612d411a68","slug":"changes","fullItemName":"Changes"},{"id":"11abf9ad-d544-577d-a891-c5a379708aed","slug":"update","fullItemName":"Update"}]},{"id":"55736356-174b-57ec-a949-beb91d4a0588","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"f4a572be-4b7a-5dd2-831f-2dd322766a65","slug":"goals","fullItemName":"Goals"},{"id":"7468eca7-2a8b-5d28-a756-280ec1cd0464","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"2da6717d-60e3-58be-9fe4-0fc22ae6d4d7","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"d29c6cc4-23ef-5837-940d-d890d90aa33f","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"8818b707-787c-51f1-9007-fecb6a288a42","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"1e00743e-81b9-5ac8-b01f-4420d8c68b7f","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"39107ffb-18a4-5a9d-8131-c82505adb09c","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"d58cc01b-2d33-5685-91a3-e9d59574c64d","slug":"definition","fullItemName":"Definition"},{"id":"a6fba973-e2b5-5eb0-a063-1bb336822fd0","slug":"causes","fullItemName":"Causes"},{"id":"793adffe-ef81-5f79-ab01-6c897d35ec86","slug":"prevalence","fullItemName":"Prevalence"},{"id":"7d076a78-65a8-52bf-afc2-f4a0d24ce69b","slug":"complications","fullItemName":"Complications"},{"id":"7e75d866-d16d-54e5-abdc-52799a96b2fd","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"94a90a22-6b78-544b-98f0-8f49469d7022","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"a65f2b2d-ebde-518c-8aff-0bf46dde42ad","slug":"diagnosing-the-cause","fullItemName":"Diagnosing the cause"}]},{"id":"6b54d469-8077-579a-aad8-21a2ab946d6d","slug":"management","fullItemName":"Management","subChapters":[{"id":"a51c56c5-9d90-5194-8d4c-0433122f7ee8","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"5bc31f90-4751-5459-b9e5-7dbb124672e5","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"9e06b9f3-0d6a-5349-88a2-1a419eb8bbc7","slug":"paracetamol-ibuprofen","fullItemName":"Paracetamol and ibuprofen"},{"id":"d99bdb44-8580-5ebb-a68b-3a1e1f822b8e","slug":"clarithromycin-erythromycin","fullItemName":"Clarithromycin and erythromycin"},{"id":"f21e5d05-51a3-5269-89a7-1cd1dfa352c1","slug":"phenoxymethylpenicillin","fullItemName":"Phenoxymethylpenicillin"}]},{"id":"9c3bce6b-ef05-5894-b906-ebccbff4fff7","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"9642452f-8502-5e85-9e59-8aea1e5a9996","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"579fc7ee-bad3-53f9-a1f1-b2412d296c59","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"2807a9ce-d5d7-5d5b-9a3d-cb18d70b51a0","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"91281f6e-4047-5b51-8bfb-1db3fc6e5b25","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"3fadc0e8-a0b9-5471-b119-9c8264f2d302","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"243cf86e-53bf-5d72-8adc-a551dbece129","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"4f26f8fe-168a-5d87-8f26-59783d95e902","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"b9203bc1-aec0-515e-b8a8-df5fbd75f255","topicId":"a235ee81-d6c7-4837-95b1-fc8ac97489f1","topicName":"Sore throat - acute","slug":"sore-throat-acute","aliases":[],"topicSummary":"The term 'sore throat' describes the symptom of pain at the back of the mouth.","lastRevised":"Last revised in January 2021","nextPlannedReviewBy":"2022-08-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2022-07","nextPlannedReviewByDisplay":"July 2022","specialities":[{"id":"bb606678-e2cc-550b-bd11-bd7b8e7d05e1","name":"Ear, nose and throat","slug":"ear-nose-throat"},{"id":"164e61aa-02a9-5edf-9943-5d891add3a7f","name":"Respiratory","slug":"respiratory"}],"chapters":[{"id":"81404cee-5cce-5697-afc1-b29dbea3cf99","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"7b8dd3db-314e-5c48-8169-957babf68c00","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"3f5b8783-adcd-5d7a-9330-002285fe81e4","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"ecd64c56-4cd5-5be5-a040-00612d411a68","slug":"changes","fullItemName":"Changes"},{"id":"11abf9ad-d544-577d-a891-c5a379708aed","slug":"update","fullItemName":"Update"}]},{"id":"55736356-174b-57ec-a949-beb91d4a0588","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"f4a572be-4b7a-5dd2-831f-2dd322766a65","slug":"goals","fullItemName":"Goals"},{"id":"7468eca7-2a8b-5d28-a756-280ec1cd0464","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"2da6717d-60e3-58be-9fe4-0fc22ae6d4d7","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"d29c6cc4-23ef-5837-940d-d890d90aa33f","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"8818b707-787c-51f1-9007-fecb6a288a42","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"1e00743e-81b9-5ac8-b01f-4420d8c68b7f","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"39107ffb-18a4-5a9d-8131-c82505adb09c","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"d58cc01b-2d33-5685-91a3-e9d59574c64d","slug":"definition","fullItemName":"Definition"},{"id":"a6fba973-e2b5-5eb0-a063-1bb336822fd0","slug":"causes","fullItemName":"Causes"},{"id":"793adffe-ef81-5f79-ab01-6c897d35ec86","slug":"prevalence","fullItemName":"Prevalence"},{"id":"7d076a78-65a8-52bf-afc2-f4a0d24ce69b","slug":"complications","fullItemName":"Complications"},{"id":"7e75d866-d16d-54e5-abdc-52799a96b2fd","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"94a90a22-6b78-544b-98f0-8f49469d7022","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"a65f2b2d-ebde-518c-8aff-0bf46dde42ad","slug":"diagnosing-the-cause","fullItemName":"Diagnosing the cause"}]},{"id":"6b54d469-8077-579a-aad8-21a2ab946d6d","slug":"management","fullItemName":"Management","subChapters":[{"id":"a51c56c5-9d90-5194-8d4c-0433122f7ee8","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"5bc31f90-4751-5459-b9e5-7dbb124672e5","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"9e06b9f3-0d6a-5349-88a2-1a419eb8bbc7","slug":"paracetamol-ibuprofen","fullItemName":"Paracetamol and ibuprofen"},{"id":"d99bdb44-8580-5ebb-a68b-3a1e1f822b8e","slug":"clarithromycin-erythromycin","fullItemName":"Clarithromycin and erythromycin"},{"id":"f21e5d05-51a3-5269-89a7-1cd1dfa352c1","slug":"phenoxymethylpenicillin","fullItemName":"Phenoxymethylpenicillin"}]},{"id":"9c3bce6b-ef05-5894-b906-ebccbff4fff7","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"9642452f-8502-5e85-9e59-8aea1e5a9996","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"579fc7ee-bad3-53f9-a1f1-b2412d296c59","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"2807a9ce-d5d7-5d5b-9a3d-cb18d70b51a0","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"91281f6e-4047-5b51-8bfb-1db3fc6e5b25","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"3fadc0e8-a0b9-5471-b119-9c8264f2d302","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"243cf86e-53bf-5d72-8adc-a551dbece129","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"4f26f8fe-168a-5d87-8f26-59783d95e902","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"b9203bc1-aec0-515e-b8a8-df5fbd75f255"}},"staticQueryHashes":["3666801979"]}